A peptide inhibitor of C-JUN N-terminal kinase modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation

Shock

Volumn 30, Issue 2, 2008, Pages 159-165

  Lehnert, Mark ^a   Relja, Borna ^a   Sun Young Lee, Veronika ^a   Schwestka, Birgit ^a   Henrich, Dirk ^a   Czerny, Christoph ^a   Froh, Matthias ^b   Borsello, Tiziana ^c   Marzi, Ingo ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Hemorrhage resuscitation; In vivo JNK inhibition; Inflammation; Mitogen activated protein kinase

Indexed keywords

4 HYDROXYNONENAL; ALANINE AMINOTRANSFERASE; CREATINE KINASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; RINGER LACTATE SOLUTION; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; AUTACOID; D JNKI 1, MOUSE; D-JNKI-1, MOUSE; PEPTIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; CELL INFILTRATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; HEMORRHAGIC SHOCK; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; RESUSCITATION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING; ANIMAL; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; LIVER; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; VASCULARIZATION;

ANIMALS; BLOOD PRESSURE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MALE; PEPTIDES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; SHOCK, HEMORRHAGIC;

EID: 52149106708     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31815dd623     Document Type: Article

References (40)

1. Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 10:79-89, 1998.
2. Keel M, Trentz O: Pathophysiology of polytrauma. Injury 36:691-709, 2005.
3. Heckbert SR, Vedder NB, Hoffman W, Winn RK, Hudson LD, Jurkovich GJ, Copass MK, Harlan JM, Rice CL, Maier RV: Outcome after hemorrhagic shock in trauma patients. J Trauma 45:545-549, 1998.
4. Shimizu T, Yu HP, Hsieh YC, Choudhry MA, Suzuki T, Bland KI, Chaudry IH: Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway. Ann Surg 245:297-304, 2007.
5. Gaddipati JP, Sundar SV, Calemine J, Seth P, Sidhu GS, Maheshwari RK: Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage/resuscitation. Shock 19:150-156, 2003.
6. Rensing H, Bauer I, Peters I, Wein T, Silomon M, Jaeschke H, Bauer M: Role of reactive oxygen species for hepatocellular injury and heme oxygenase-1 gene expression after hemorrhage and resuscitation. Shock 12:300-308, 1999.
7. Dugo L, Abdelrahman M, Murch O, Mazzon E, Cuzzocrea S, Thiemermann C: Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation. Shock 25:485-491, 2006.
8. Akgur FM, Brown MF, Zibari GB, McDonald JC, Epstein CJ, Ross CR, Granger DN: Role of superoxide in hemorrhagic shock-induced P-selectin expression. Am J Physiol Heart Circ Physiol 279:H791-H797, 2000.
9. Cockerill GW, McDonald MC, Mota-Filipe H, Cuzzocrea S, Miller NE, Thiemermann C: High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock. FASEB J 15:1941-1952, 2001.
10. Liaw WJ, Chen TH, Lai ZZ, Chen SJ, Chen A, Tzao C, Wu JY, Wu CC: Effects of a membrane-permeable radical scavenger, Tempol, on intraperitoneal sepsis-induced organ injury in rats. Shock 23:88-96, 2005.
11. Maier B, Schwerdtfeger K, Mautes A, Holanda M, Muller M, Steudel WI, Marzi I: Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock 15:421-426, 2001.
12. Seth P, Sundar SV, Seth RK, Sidhu GS, Sharma SC, Kulshreshtha DK, Maheshwari RK: Picroliv modulates antioxidant status and down-regulates AP1 transcription factor after hemorrhage and resuscitation. Shock 19:169-175, 2003.
13. Bauer C, Walcher F, Holanda M, Mertzlufft F, Larsen R, Marzi I: Antioxidative resuscitation solution prevents leukocyte adhesion in the liver after hemorrhagic shock. J Trauma 46:886-893, 1999.
14. Bahrami S, Yao YM, Leichtfried G, Redl H, Marzi I, Schlag G: Significance of TNF in hemorrhage-related hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol 272:H2219-H2226, 1997.
15. Karin M: Mitogen-activated protein kinase cascades as regulators of stress responses. Ann N Y Acad Sci 851:139-146, 1998.
16. Rensing H, Jaeschke H, Bauer I, Patau C, Datene V, Pannen BH, Bauer M: Differential activation pattern of redox-sensitive transcription factors and stress-inducible dilator systems heme oxygenase-1 and inducible nitric oxide synthase in hemorrhagic and endotoxic shock. Crit Care Med 29:1962-1971, 2001.
17. Lehnert M, Uehara T, Bradford BU, Lind H, Zhong Z, Brenner DA, Marzi I, Lemasters JJ: Lipopolysaccharide-binding protein modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation. Am J Physiol Gastrointest Liver Physiol 291:G456-G463, 2006.
18. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF: In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569-1572, 1999.
19. Borsello T, Clarke PG, Hirt L, Vercelli A, Repici M, Schorderet DF, Bogousslavsky J, Bonny C: A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med 9:1180-1186, 2003.
20. Bertelsen M, Sanfridson A: Inflammatory pathway analysis using a high content screening platform. Assay Drug Dev Technol 3:261-271, 2005.
21. Zhong Z, Enomoto N, Connor HD, Moss N, Mason RP, Thurman RG: Glycine improves survival after hemorrhagic shock in the rat. Shock 12:54-62, 1999.
22. Paxian M, Rensing H, Rickauer A, Schonhofen S, Schmeck J, Pannen BH, Bauer I, Bauer M: Kupffer cells and neutrophils as paracrine regulators of the heme oxygenase-1 gene in hepatocytes after hemorrhagic shock. Shock 15:438-445, 2001.
23. Paxian M, Bauer I, Rensing H, Jaeschke H, Mautes AE, Kolb SA, Wolf B, Stockhausen A, Jeblick S, Bauer M: Recovery of hepatocellular ATP and Bpericentral apoptosis[ after hemorrhage and resuscitation. FASEB J 17:993-1002, 2003.
24. McCloskey CA, Kameneva MV, Uryash A, Gallo DJ, Billiar TR: Tissue hypoxia activates JNK in the liver during hemorrhagic shock. Shock 22:380-386, 2004.
25. Uehara T, Xi PX, Bennett B, Satoh Y, Friedman G, Currin R, Brenner DA, Lemasters J: c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation 78:324-332, 2004.
26. Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, Westwick JK, Brenner DA: JNK mediates hepatic ischemia reperfusion injury. J Hepatol 42:850-859, 2005.
27. Bonny C, Nicod P, Waeber G: IB1, a JIP-1-related nuclear protein present in insulin-secreting cells. J Biol Chem 273:1843-1846, 1998.
28. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ: A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277:693-696, 1997.
29. Lehnert M, Arteel GE, Smutney OM, Conzelmann LO, Zhong Z, Thurman RG, Lemasters JJ: Dependence of liver injury after hemorrhage/resuscitation in mice on NADPH oxidase-derived superoxide. Shock 19:345-351, 2003.
30. Lemasters JJ, Thurman RG: Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 37:327-338, 1997.
31. Karin M, Gallagher E: From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57:283-295, 2005.
32. Paxian M, Bauer I, Kaplan D, Bauer M, Rensing H: Hepatic redox regulation of transcription factors activator protein-1 and nuclear factor-kappaB after hemorrhagic shock in vivo. Antioxid Redox Signal 4:711-720, 2002.
33. Abdelrahman M, Mazzon E, Bauer M, Bauer I, Delbosc S, Cristol JP, Patel NS, Cuzzocrea S, Thiemermann C: Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock. Shock 23:107-114, 2005.
34. Meng ZH, Dyer K, Billiar TR, Tweardy DJ: Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol 280:C343-C351, 2001.
35. Toth B, Yokoyama Y, Schwacha MG, George RL, Rue LW, III, Bland KI, Chaudry IH: Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shock. J Appl Physiol 97:2184-2189, 2004.
36. Aderka D, Le JM, Vilcek J: IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 143:3517-3523, 1989.
37. Yoshizawa K, Naruto M, Ida N: Injection time of interleukin-6 determines fatal outcome in experimental endotoxin shock. J Interferon Cytokine Res 16:995-1000, 1996.
38. de HS, Bakker AC, van der Geest RN, Haegeman G, Vanden BW, Aarbiou J, Daha MR, van KC: NF-kappaB mediated IL-6 production by renal epithelial cells is regulated by c-jun NH2-terminal kinase. J Am Soc Nephrol 16:1603-1611, 2005.
39. Gujral JS, Bucci TJ, Farhood A, Jaeschke H: Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 33:397-405, 2001.
40. Lemasters JJ: V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol 276:G1-G6, 1999.